It is called Green Impact Index and is a tool designed to measure and communicate to consumers the environmental and social impact of cosmetic and health products through an alphabetical classification (A, B, C or D). It was presented by the Pierre Fabre group – the second dermocosmetics laboratory in the world and the second private pharmaceutical group in France – confirming its commitment to transparency and sustainability. In addition to providing information to consumers, in fact, the index will allow the group to improve the profile of its products with the aim of having, by 2023, half of the portfolio designed in an eco-socially sustainable way. The scores of the first references of the Avène, A-Derma, Ducray, Klorane, René Furterer and Naturactive brands are already available on the group’s corporate website. Others will be rated and published on a monthly basis and scores will be visible directly on brands’ websites by the end of the year.
«Innovation, transparency and sustainability are the key to development – comments Eric Ducournau, general manager of the Pierre Fabre group -. The Green Impact Index is a response to the growing distrust of consumers and patients in the ability of brands to respect the environment, to engage on a social level and to communicate in a transparent and verifiable manner. We have always paid great attention to these issues and this index is today tangible proof of this ».
In 2020, Pierre Fabre generated € 2.3 billion in revenues, of which 65% internationally. Founded in 1962 in the Occitania region, producing over 95% of its products in France, the group employs nearly 10,000 people worldwide and distributes its products in around 130 countries. It is mainly controlled by a recognized foundation of public utility, the Pierre Fabre Foundation, which holds 86% of the capital.
The company has launched a Transformation Plan for the four-year period 2020-2023 based on the principle that taking care of a single person means improving the whole world. «Our business model focuses on an integrated approach to health that includes prevention, treatment and support – explains Ducournau -. The year in which we launched the Transformation Plan coincided with an unprecedented health and economic crisis, but this did not stop us: we continued to work ensuring the safety of our employees and ensuring continuity of service to patients – mainly oncologists – and consumers. We started our new IT system and organizational change. And for this year we have ambitious goals: triple our profit, reach 70% of business outside France, grow in dermocosmetics and focus on cancer drugs as well as continue our commitment to sustainability by reducing the carbon intensity of ours. activities and implementing the eco and social responsibility of the design of our products. Finally, we will focus on a cultural transformation of our company by adopting new ways of working to reach a higher level of simplification and transversality ».